Demant A/S, commonly known as Demant, is a leading global player in the hearing healthcare and personal communication industry, headquartered in Denmark (DK). Founded in 1904, the company has evolved significantly, marking key milestones such as the introduction of innovative hearing aids and advanced audiometric equipment. Demant operates extensively across Europe, North America, and Asia, focusing on hearing aids, audiometric instruments, and personal communication solutions. Their core products, renowned for their cutting-edge technology and user-centric design, set them apart in a competitive market. With a strong commitment to research and development, Demant has established itself as a trusted name, achieving notable recognition for its contributions to improving the quality of life for individuals with hearing loss.
How does Demant's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Demant's score of 81 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Demant reported total carbon emissions of approximately 493,529,000 kg CO2e, comprising 14,645,000 kg CO2e from Scope 1, 14,781,000 kg CO2e from Scope 2, and a significant 464,103,000 kg CO2e from Scope 3 emissions. This data reflects a commitment to transparency and accountability in their environmental impact. Demant has set ambitious climate targets, aiming for a minimum 50% reduction in Scope 1 and 2 emissions by 2030, using 2019 as the baseline. Furthermore, they are committed to achieving a 90% reduction in both Scope 1 and 2 emissions by 2050. For Scope 3 emissions, the company also targets a 46.2% reduction by 2030 and a 90% reduction by 2050. These targets align with the Science Based Targets initiative (SBTi) and demonstrate Demant's commitment to reaching net-zero greenhouse gas emissions across its value chain by 2050. The company is classified as a member of the BA1.5, indicating its alignment with the 1.5°C climate goal. Overall, Demant's emissions data and reduction commitments reflect a proactive approach to addressing climate change, positioning the company as a responsible leader in the healthcare technology sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 4,368,000  | -  | 00,000,000  | 0,000,000  | 0,000,000  | 00,000,000  | 00,000,000  | 00,000,000  | 
| Scope 2 | 19,897,000  | -  | 00,000,000  | 00,000,000  | 00,000,000  | 00,000,000  | 00,000,000  | 00,000,000  | 
| Scope 3 | -  | -  | 000,000,000  | 000,000,000  | 000,000,000  | 000,000,000  | 000,000,000  | 000,000,000  | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Demant has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Demant's sustainability data and climate commitments